Related references
Note: Only part of the references are listed.The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma A Report by the American Academy of Ophthalmology
Ambika Hoguet et al.
OPHTHALMOLOGY (2019)
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema A DRCR Network Phase 2 Randomized Clinical Trial
Raj K. Maturi et al.
JAMA OPHTHALMOLOGY (2018)
The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema
Gabriele E. Lang et al.
ACTA OPHTHALMOLOGICA (2018)
Diabetes 2030: Insights from Yesterday, Today, and Future Trends
William R. Rowley et al.
POPULATION HEALTH MANAGEMENT (2017)
Vascular Safety of Ranibizumab in Patients With Diabetic Macular Edema A Pooled Analysis of Patient-Level Data From Randomized Clinical Trials
Marco A. Zarbin et al.
JAMA OPHTHALMOLOGY (2017)
Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials
Ronald P. Danis et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study
Yasir J. Sepah et al.
OPHTHALMOLOGY (2016)
Intravitreal Aflibercept for Diabetic Macular Edema 148-Week Results from the VISTA and VIVID Studies
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
John A. Wells et al.
OPHTHALMOLOGY (2016)
Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial
Lee M. Jampol et al.
JAMA OPHTHALMOLOGY (2016)
Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial
Eric L. Ross et al.
JAMA OPHTHALMOLOGY (2016)
Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study
Paul Mitchell et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose)
D. V. Do et al.
EYE (2015)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
John A. Wells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Intravitreal Aflibercept for Diabetic Macular Edema 100-Week Results From the VISTA and VIVID Studies
David M. Brown et al.
OPHTHALMOLOGY (2015)
The REVEAL Study Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema
Tatsuro Ishibashi et al.
OPHTHALMOLOGY (2015)
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study
Albert J. Augustin et al.
BMC OPHTHALMOLOGY (2015)
Vision-Related Function after Ranibizumab Treatment for Diabetic Macular Edema
Neil M. Bressler et al.
OPHTHALMOLOGY (2014)
Intravitreal Aflibercept for Diabetic Macular Edema
Jean-Francois Korobelnik et al.
OPHTHALMOLOGY (2014)
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
David S. Boyer et al.
OPHTHALMOLOGY (2014)
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
K. Ghasemi Falavarjani et al.
EYE (2013)
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials RISE and RIDE
David M. Brown et al.
OPHTHALMOLOGY (2013)
Patient-Reported Visual Function Outcomes Improve After Ranibizumab Treatment in Patients With Vision Impairment Due to Diabetic Macular Edema Randomized Clinical Trial
Paul Mitchell et al.
JAMA OPHTHALMOLOGY (2013)
Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2012)
Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2012)
Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2011)
The RESTORE Study Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema
Paul Mitchell et al.
OPHTHALMOLOGY (2011)
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
Pascale Massin et al.
DIABETES CARE (2010)
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Michael J. Elman et al.
OPHTHALMOLOGY (2010)
Incidence of rainbow glare after laser in situ keratomileusis flap creation with a 60 kHz femtosecond laser
Sonya Bamba et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2009)
Share Paper
